Vosevi

Kathryn Dzintars, Pharm.D., BCPS
Vosevi is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of adult patients with chronic HCV infection without cirrhosis or compensated cirrhosis (Child-Pugh A) who have:
    • Genotype 1, 2, 3, 4, 5 or 6 infection who have previously been treated with an HCV regimen containing an NS5A inhibitor
    • Genotype 1a or 3 infection and have been previously treated with sofosbuvir without an NS5A inhibitor

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: June 4, 2018

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Vosevi ID - 540689 A1 - Dzintars,Kathryn,Pharm.D., BCPS Y1 - 2018/06/04/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540689/all/Vosevi PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -